Madecassic acid nrog CAS 18449-41-7
Madecassic acid yog ib qho triterpenoid uas tau pom muaj nyob rau hauv C. asiatica thiab muaj ntau yam kev ua haujlwm ntawm lub cev. Nws inhibits LPS-induced kev tsim cov nitric oxide (NO), prostaglandin E2 (PGE2; Khoom No. 14010), TNF-α, IL-1β, thiab IL-6 hauv RAW 264.7 macrophages thaum siv ntawm qhov concentration ntawm 150 μg / ml. Madecassic acid (0.05 thiab 0.1% hauv kev noj haus) txo cov plasma theem ntawm fibrinogenin thiab triglycerides, nrog rau lub plawv thiab lub raum theem ntawm cov reactive oxygen hom (ROS), hauv tus qauv nas ntawm ntshav qab zib uas tshwm sim los ntawm streptozotocin (STZ; Khoom No. 13104). Nws txo qhov kev loj hlob ntawm qog hauv CT26 murine colon cancer qauv nyob ntawm seb muaj pes tsawg.
| CAS | 18449-41-7 |
| Cov Npe | Madecassic acid |
| Qhov tsos | Hmoov |
| Kev dawb huv | 98% |
| MF | C30H48O6 |
| Qib | Khoom noj $ Qib kho mob |
| Pob khoom | 25kgs/hnab, 20tons/20'thawv |
| Lub Npe Hom | Unilong |
Madecassic Acid yog ib qho terpenoid nrog ib lub pob txha ursane cais los ntawm Centella asiatica. Madecassic Acid qhia txog cov khoom tiv thaiv kev o vim yog iNOS, COX-2, TNF-alpha, IL-1beta, thiab IL-6 inhibition los ntawm kev txo qis ntawm NF-kappaB activation hauv RAW 264.7 macrophage hlwb.
25kgs/nruas, 9tons/20'thawv
25kgs/hnab, 20tons/20'thawv
odium-dodecylbenzenesulphonate
